Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 907,879 | 1,272,958 | 1,459,302 | 968,086 | 816,007 |
| Marketable Securities | 1,190,789 | 384,017 | 330,760 | 203,892 | 120,844 |
| Receivables | 1,621,966 | 1,389,534 | 1,023,397 | 795,127 | 609,320 |
| Inventories | 1,203,809 | 1,051,771 | 927,868 | 599,966 | 564,145 |
| Income taxes - deferred | 279,339 | 295,080 | 140,882 | 152,533 | 245,916 |
| Other current assets | 116,244 | 66,891 | 126,066 | 35,242 | 22,863 |
| TOTAL | $5,708,082 | $4,812,558 | $4,278,408 | $3,028,292 | $2,429,206 |
| Non-Current Assets | |||||
| PPE Net | 701,235 | 699,970 | 528,799 | 447,696 | 361,299 |
| Investments And Advances | 3,219,403 | 2,247,871 | 1,449,577 | 1,550,444 | 452,715 |
| Intangibles | 1,425,592 | 1,524,777 | 123,008 | 0 | 0 |
| Other Non-Current Assets | 538,318 | 413,383 | 557,039 | 808,284 | 842,761 |
| TOTAL | $5,884,548 | $4,886,001 | $2,658,423 | $2,806,424 | $1,656,775 |
| Total Assets | $11,592,630 | $9,698,559 | $6,936,831 | $5,834,716 | $4,085,981 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 5,631 | 286 | 18,747 |
| Accounts payable and accrued liabilities | 803,025 | 810,544 | 601,200 | 290,333 | 367,029 |
| Accrued Expenses | 472,650 | 381,141 | 280,779 | 251,688 | 75,659 |
| TOTAL | $2,464,950 | $1,871,631 | $1,220,992 | $736,275 | $764,276 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,865,974 | 35,918 | 21,462 | 11,604 | 91,847 |
| Deferred Revenues | 103,175 | 122,721 | 42,963 | 30,747 | 17,777 |
| Other Non-Current Liabilities | 118,533 | 1,252,989 | 1,163,177 | 1,574,639 | 1,353,091 |
| TOTAL | $3,005,843 | $1,321,770 | $1,250,256 | $1,638,451 | $1,505,987 |
| Total Liabilities | $5,470,793 | $3,193,401 | $2,471,248 | $2,374,726 | $2,270,263 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,590,529 | 1,806,758 | 1,821,909 | 1,857,740 | 1,858,656 |
| Common Shares | 802 | 900 | 910 | 932 | 922 |
| Retained earnings | 1,183,730 | 1,995,272 | 300,314 | 249,080 | -891,363 |
| Other shareholders' equity | 289,019 | 132,335 | 234,250 | -4,363 | 2,221 |
| TOTAL | $6,121,837 | $6,505,158 | $4,465,583 | $3,459,990 | $1,815,718 |
| Total Liabilities And Equity | $11,592,630 | $9,698,559 | $6,936,831 | $5,834,716 | $4,085,981 |